Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim J Kruser

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Systemic Therapy in Unresectable Meningioma Before RadiotherapyTim J Kruser
International Journal of Radiation Oncology, Biology, Physics|March 15, 2025
Contouring with FLAIR: Targeting Peritumoral Edema (and Beyond) in GlioblastomaJerome M Karp, Tim J Kruser
International Journal of Radiation Oncology, Biology, Physics|September 8, 2019
A Time to Ignore "No Meat, No Treat"Tim J Kruser, Jeffrey A Sosman
Experimental Cell Research|January 13, 2010
Mechanisms of resistance to HER family targeting antibodiesTim J Kruser, Deric L Wheeler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2017
Getting to the Heart of the Matter: What Additional Proof Is Needed to Demonstrate the Value of Intensity-Modulated Radiotherapy in Thoracic Oncology?Jeffrey P Gross, Tim J Kruser
The Lancet. Oncology|September 9, 2017
Primary medical therapy for BRAF<sup>V600E</sup>-mutant melanoma brain metastases-is this good enough?Tim J Kruser, Michael A Vogelbaum
Clinical Neurology and Neurosurgery|February 21, 2019
Symptomatic radiation necrosis in brain metastasis patients treated with stereotactic radiosurgery and immunotherapyNoah Weingarten, Tim J Kruser, Orin Bloch
The Journal of Thoracic and Cardiovascular Surgery|April 24, 2018
One size does not fit all: Nuances in postoperative N2 non-small cell lung cancer managementTim J Kruser, Nisha Mohindra, Malcolm M DeCamp
PET Clinics|May 10, 2016
Principles and Application of PET in Brain TumorsDonald M Cannon, Tim J Kruser, Deepak Khuntia
Expert Opinion on Investigational Drugs|January 6, 2011
The use of single-agent dasatinib in molecularly unselected non-small-cell lung cancer patientsTim J Kruser, Anne M Traynor, Deric L Wheeler
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Systemic Therapy in Unresectable Meningioma Before RadiotherapyTim J Kruser
International Journal of Radiation Oncology, Biology, Physics|March 15, 2025
Contouring with FLAIR: Targeting Peritumoral Edema (and Beyond) in GlioblastomaJerome M Karp, Tim J Kruser
International Journal of Radiation Oncology, Biology, Physics|September 8, 2019
A Time to Ignore "No Meat, No Treat"Tim J Kruser, Jeffrey A Sosman
Experimental Cell Research|January 13, 2010
Mechanisms of resistance to HER family targeting antibodiesTim J Kruser, Deric L Wheeler
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 9, 2017
Getting to the Heart of the Matter: What Additional Proof Is Needed to Demonstrate the Value of Intensity-Modulated Radiotherapy in Thoracic Oncology?Jeffrey P Gross, Tim J Kruser
The Lancet. Oncology|September 9, 2017
Primary medical therapy for BRAF<sup>V600E</sup>-mutant melanoma brain metastases-is this good enough?Tim J Kruser, Michael A Vogelbaum
Clinical Neurology and Neurosurgery|February 21, 2019
Symptomatic radiation necrosis in brain metastasis patients treated with stereotactic radiosurgery and immunotherapyNoah Weingarten, Tim J Kruser, Orin Bloch
The Journal of Thoracic and Cardiovascular Surgery|April 24, 2018
One size does not fit all: Nuances in postoperative N2 non-small cell lung cancer managementTim J Kruser, Nisha Mohindra, Malcolm M DeCamp
PET Clinics|May 10, 2016
Principles and Application of PET in Brain TumorsDonald M Cannon, Tim J Kruser, Deepak Khuntia
Expert Opinion on Investigational Drugs|January 6, 2011
The use of single-agent dasatinib in molecularly unselected non-small-cell lung cancer patientsTim J Kruser, Anne M Traynor, Deric L Wheeler
Pageof 6